Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.08
-0.27 (-4.25%)
At close: Nov 16, 2026, 4:00 PM EST
6.19
+0.11 (1.81%)
After-hours: Nov 16, 2026, 7:33 PM EST
Cartesian Therapeutics Revenue
Cartesian Therapeutics had revenue of $1.03M in the twelve months ending September 30, 2026, down -6.05% year-over-year. In the year 2025, Cartesian Therapeutics had annual revenue of $2.80M, down -92.81%. That makes Cartesian Therapeutics the 43,607th largest company in the world by revenue and 6,093rd in the United States.
Revenue (ttm)
$1.03M
Revenue Growth
-6.05%
P/S Ratio
180.93
Revenue / Employee
$13,667
Employees
75
Market Cap
185.46M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.80M | -36.12M | -92.81% |
| Dec 31, 2024 | 38.91M | 12.91M | 49.64% |
| Dec 31, 2023 | 26.00M | -84.77M | -76.53% |
| Dec 31, 2022 | 110.78M | 25.70M | 30.21% |
| Dec 31, 2021 | 85.08M | 68.48M | 412.60% |
| Dec 31, 2020 | 16.60M | 9.92M | 148.57% |
| Dec 31, 2019 | 6.68M | 5.77M | 639.42% |
| Dec 31, 2018 | 903.00K | 696.00K | 336.23% |
| Dec 31, 2017 | 207.00K | -7.88M | -97.44% |
| Dec 31, 2016 | 8.08M | 2.07M | 34.47% |
| Dec 31, 2015 | 6.01M | 2.97M | 97.73% |
| Dec 31, 2014 | 3.04M | 1.56M | 105.54% |
| Dec 31, 2013 | 1.48M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Compugen | 75.93M |
| Keros Therapeutics | 40.76M |
| ProQR Therapeutics | 23.46M |
| Alpha Cognition | 20.20M |
| Pyxis Oncology | 11.04M |
| MediWound | 10.01M |
| Entrada Therapeutics | 3.98M |
| Korro Bio | 1.29M |
RNAC News
- 10 hours ago - Cartesian Therapeutics management to meet virtually with Needham - TheFly
- 7 days ago - Cartesian Therapeutics management to meet virtually with Needham - TheFly
- 11 days ago - Cartesian Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 11 days ago - Cartesian Therapeutics Quarterly report: Q3 2026 - Filings
- 11 days ago - Cartesian Therapeutics Earnings release: Q3 2026 - Filings
- 13 days ago - Cartesian Therapeutics Announces New Employment Inducement Grant - GlobeNewsWire
- 6 weeks ago - Cartesian Therapeutics Announces New Employment Inducement Grants - GlobeNewsWire
- 6 weeks ago - Cartesian Therapeutics announces positive retreatment data on Descartes-08 - TheFly